EXAS Description — EXACT Sciences Corp.

Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.

Company Name: 
EXACT Sciences Corp.
Number of ETFs Holding EXAS: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   EXAS Weight   EXAS Amount 
 ARKK   6.25%   $447,903,253         
 VTI   0.03%   $349,879,158         
 VB   0.27%   $296,128,760         
 ARKG   11.72%   $213,734,686         
 VBK   0.61%   $170,931,428         
 VXF   0.19%   $155,564,981         
 XBI   1.03%   $67,785,675         
 FBT   3.41%   $48,536,981         
 VHT   0.21%   $39,662,368         
 FXH   2.14%   $32,450,662         
List of all 50 ETFs holding EXAS »
Quotes delayed 20 minutes

Email EnvelopeFree EXAS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.54 out of 4)
59th percentile
(ranked higher than approx. 59% of all stocks covered)

Analysts Forecast:
EXAS Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding EXAS | EXACT Sciences Corp. | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.